Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Titel:
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Auteur:
Martin, Miguel Brase, Jan C. Ruiz, Amparo Prat, Aleix Kronenwett, Ralf Calvo, Lourdes Petry, Christoph Bernard, Philip S. Ruiz-Borrego, Manuel Weber, Karsten E. Rodriguez, César A. Alvarez, Isabel M. Segui, Miguel A. Perou, Charles M. Casas, Maribel Carrasco, Eva Caballero, Rosalía Rodriguez-Lescure, Alvaro